(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab ... Products for Human Use recommended the approval of the drug in combination with gemcitabine and cisplatin as ...

In a study sponsored by AstraZeneca, researchers found that using the firm’s Imfinzi drug before and after surgery reduced the odds by 29% over a two-year period that a nasty type of operable ...

AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN) announced today that its drug Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) as a treatment for adult patients with ...

PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.

AstraZeneca PLC (LSE/STO/Nasdaq:LON:AZN) announced today that its drug Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) as a treatment for adult patients with ...

the target of blockbuster drugs Imfinzi and Tecentriq, and VEGF, the target of the blockbuster Avastin. A similar experimental antibody drug, from Summit Therapeutics and the Chinese firm Akeso ...

Ovarian cancer remains a significant global health challenge, often diagnosed at an advanced stage due to non-specific ...

Kunz cautioned about patient selection from a tolerability standpoint because FLOT already has four drugs: 5-fluorouracil, leucovorin, oxaliplatin and docetaxel. Janjigan described the Imfinzi’s ...